Neuroendocrine cells concentrate protein hormones into aggregates that form dense cores of secretory granules, a basic process whose mechanism is not known. A model is that cargo proteins diffuse to the area where secretory granules form, and specific actions occur there that change the conformation of cargo proteins so that the aggregate; the actions are not the same for all proteins. This model was developed because there is unexpected specificity in a pituitary cell line for cargo protein storage, which may reflect unrecognized specificity in the ability of the cells to aggregate proteins into dense cores. If aggregation of cargo proteins in cells is really so specific, then: 1. neuroendocrine cells will differ in their ability to aggregate cargo proteins into dense cores, and 2. the structures required for aggregation of each protein will have precise requirements, which may differ from what is required for aggregation in solution. The first two aims determine whether aggregation in intact cells is specific and determine the structures necessary.
The third aim i nvestigates another aspect of hormone production in the secretory pathway: how production of cargo protein mRNAs are regulated by feedback from that pathway. Expression of a mutant human prolactin, H27A, suppressed rat prolactin synthesis, an effect similar to dominant-negative deficiency of growth hormone and vasopressin found in people. A hypothesis that may explain the action of all these mutants is that cargo proteins that are unstable or difficult to fold result in a signal from the secretory pathway to the nucleus that reduces transcription of mRNA for all cargo proteins made by the cell.
The third aim i s to determine the means by which human H27A-prolactin, human H183R-growth hormone and human des32-71- growth hormone exert dominant-negative effects on hormone production. The knowledge of how hormone production and packaging is controlled in the secretory pathway will increase the ability to understand the pathogenesis of diseases such as diabetes and develop more effective treatments.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
2R01DK046807-05A1
Application #
2693171
Study Section
Biochemical Endocrinology Study Section (BCE)
Program Officer
Sato, Sheryl M
Project Start
1993-07-15
Project End
2002-06-30
Budget Start
1998-09-10
Budget End
1999-06-30
Support Year
5
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Yale University
Department
Pharmacology
Type
Schools of Medicine
DUNS #
082359691
City
New Haven
State
CT
Country
United States
Zip Code
06520
Keeler, Camille; Hodsdon, Michael E; Dannies, Priscilla S (2004) Is there structural specificity in the reversible protein aggregates that are stored in secretory granules? J Mol Neurosci 22:43-9
Keeler, Camille; Dannies, Priscilla S; Hodsdon, Michael E (2003) The tertiary structure and backbone dynamics of human prolactin. J Mol Biol 328:1105-21
Sankoorikal, Binu-John; Zhu, Yong Lian; Hodsdon, Michael E et al. (2002) Aggregation of human wild-type and H27A-prolactin in cells and in solution: roles of Zn(2+), Cu(2+), and pH. Endocrinology 143:1302-9
Dannies, P S (2001) Concentrating hormones into secretory granules: layers of control. Mol Cell Endocrinol 177:87-93
Lee, M S; Zhu, Y L; Chang, J E et al. (2001) Acquisition of Lubrol insolubility, a common step for growth hormone and prolactin in the secretory pathway of neuroendocrine cells. J Biol Chem 276:715-21
Lee, M S; Wajnrajch, M P; Kim, S S et al. (2000) Autosomal dominant growth hormone (GH) deficiency type II: the Del32-71-GH deletion mutant suppresses secretion of wild-type GH. Endocrinology 141:883-90
Dannies, P S (2000) Protein folding and deficiencies caused by dominant-negative mutants of hormones. Vitam Horm 58:26-Jan
Lee, M S; Dirkx Jr, R; Solimena, M et al. (1998) Stabilization of the receptor protein tyrosine phosphatase-like protein ICA512 in GH4C1 cells upon treatment with estradiol, insulin, and epidermal growth factor. Endocrinology 139:2727-33
Sun, Z; Lee, M S; Rhee, H K et al. (1997) Inefficient secretion of human H27A-prolactin, a mutant that does not bind Zn2+. Mol Endocrinol 11:1544-51
Sun, Z; Li, P S; Dannies, P S et al. (1996) Properties of human prolactin (PRL) and H27A-PRL, a mutant that does not bind Zn++. Mol Endocrinol 10:265-71

Showing the most recent 10 out of 12 publications